ACADIA PHARMACEUTICALS INC Logo

ACADIA PHARMACEUTICALS INC

Biopharmaceutical company developing medicines for CNS disorders and rare diseases.

ACAD | US

Overview

Corporate Details

ISIN(s):
US0042251084
LEI:
Country:
United States of America
Address:
12830 EL CAMINO REAL, 92130 SAN DIEGO

Description

ACADIA PHARMACEUTICALS INC. is a biopharmaceutical company focused on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases. The company's commercial portfolio includes FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. Acadia is advancing a diverse clinical pipeline with mid- to late-stage programs targeting conditions such as Alzheimer's disease psychosis and Lewy body dementia psychosis, alongside early-stage programs addressing other unmet patient needs. The company's mission is to provide innovative therapies and support to underserved patient communities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2020-11-20 22:29
FORM 4 SUBMISSION
English ZIP 7.3 KB
2020-11-04 18:04
10-Q
English ZIP 1.3 MB
2020-11-04 17:37
8-K
English ZIP 113.0 KB
2020-10-29 17:12
FORM 4 SUBMISSION
English ZIP 7.9 KB
2020-10-19 19:27
FORM 4 SUBMISSION
English ZIP 7.3 KB
2020-10-19 19:26
FORM 4 SUBMISSION
English ZIP 7.3 KB
2020-10-19 19:25
FORM 4 SUBMISSION
English ZIP 7.3 KB
2020-10-01 19:30
FORM 8-K
English ZIP 70.1 KB
2020-10-01 19:04
FORM 4 SUBMISSION
English ZIP 7.1 KB
2020-10-01 19:00
FORM 3 SUBMISSION
English ZIP 7.9 KB
2020-08-25 11:26
S-3ASR
English ZIP 108.6 KB
2020-08-25 11:02
8-K
English ZIP 78.5 KB
2020-08-07 19:41
FORM 3/A SUBMISSION
English ZIP 6.1 KB
2020-08-06 19:21
8-K
English ZIP 61.4 KB
2020-08-06 19:19
S-8
English ZIP 24.6 KB

Automate Your Workflow. Get a real-time feed of all ACADIA PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ACADIA PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ACADIA PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes treatments for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharmaceutical company developing medicines for cardiorenal and gastrointestinal diseases.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharmaceutical company enhancing medicines with its proprietary formulation technology.
United Kingdom
AREC
argenx SE Logo
Develops and commercializes antibody-based therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Develops bacteriophage therapeutics for antibiotic-resistant bacterial infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets in vitro diagnostic (IVD) tests for oncology and bacteriology.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
Clinical-stage biopharma developing oncology drugs for difficult-to-treat diseases.
United States of America
AVBP
ARROWHEAD PHARMACEUTICALS, INC. Logo
Biotechnology company developing RNAi therapies to treat intractable diseases.
United States of America
ARWR
ARS Pharmaceuticals, Inc. Logo
Develops and commercializes needle-free products for administering therapies.
United States of America
SPRY
ARTELO BIOSCIENCES, INC. Logo
Clinical-stage biopharma developing therapeutics by modulating the endocannabinoid system.
United States of America
ARTL

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.